1. Home
  2. QD vs TBPH Comparison

QD vs TBPH Comparison

Compare QD & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QD
  • TBPH
  • Stock Information
  • Founded
  • QD 2014
  • TBPH 2013
  • Country
  • QD China
  • TBPH United States
  • Employees
  • QD N/A
  • TBPH N/A
  • Industry
  • QD Finance: Consumer Services
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • QD Finance
  • TBPH Health Care
  • Exchange
  • QD Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • QD 754.6M
  • TBPH 699.0M
  • IPO Year
  • QD 2017
  • TBPH N/A
  • Fundamental
  • Price
  • QD $4.12
  • TBPH $14.05
  • Analyst Decision
  • QD
  • TBPH Strong Buy
  • Analyst Count
  • QD 0
  • TBPH 4
  • Target Price
  • QD N/A
  • TBPH $23.00
  • AVG Volume (30 Days)
  • QD 392.3K
  • TBPH 516.3K
  • Earning Date
  • QD 08-13-2025
  • TBPH 11-11-2025
  • Dividend Yield
  • QD N/A
  • TBPH N/A
  • EPS Growth
  • QD N/A
  • TBPH N/A
  • EPS
  • QD 0.42
  • TBPH 0.26
  • Revenue
  • QD $19,058,373.00
  • TBPH $77,205,000.00
  • Revenue This Year
  • QD N/A
  • TBPH $79.82
  • Revenue Next Year
  • QD N/A
  • TBPH N/A
  • P/E Ratio
  • QD $9.83
  • TBPH $54.21
  • Revenue Growth
  • QD N/A
  • TBPH 24.49
  • 52 Week Low
  • QD $1.77
  • TBPH $7.88
  • 52 Week High
  • QD $5.08
  • TBPH $14.55
  • Technical
  • Relative Strength Index (RSI)
  • QD 44.40
  • TBPH 61.75
  • Support Level
  • QD $4.08
  • TBPH $13.86
  • Resistance Level
  • QD $4.37
  • TBPH $14.42
  • Average True Range (ATR)
  • QD 0.17
  • TBPH 0.43
  • MACD
  • QD -0.08
  • TBPH -0.07
  • Stochastic Oscillator
  • QD 5.22
  • TBPH 53.70

About QD Qudian Inc. each representing one

Qudian Inc is a consumer-oriented technology company engaged in the operation of online platforms to provide small consumer credit products in the People's Republic of China. It aims to empower financial institutions with its technological capabilities, help them improve marketing and operating efficiency, and enable financial institutions to efficiently connect their diversified financial products with scene traffic across the entire network It derives a majority of its revenue from the People's Republic of China.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: